BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2218420)

  • 21. Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy.
    Belliveau P; Nightingale CH; Quintiliani R; Crowe H; Gousee G
    Conn Med; 1993 Aug; 57(8):539-45. PubMed ID: 8243083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: a controlled clinical study.
    Naber KG; Sigl G
    Am J Med; 1993 Mar; 94(3A):114S-117S. PubMed ID: 8452166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
    Obana Y; Nishino T
    Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and prostatic tissue concentrations of ofloxacin.
    Fujita K; Munakata A
    Clin Ther; 1988; 10 Spec No():32-5. PubMed ID: 3233627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics of ofloxacin administered orally in elderly subjects with bronchial or urinary tract infections].
    Bardin C; Clavier M; Darchis JP; Chauvin M; Veyssier P; Farinotti R
    Therapie; 1992; 47(1):35-9. PubMed ID: 1523592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical reevaluation of ofloxacin (OFLX) in urinary tract infections].
    Akiyama T; Matsuura T; Kurita T
    Hinyokika Kiyo; 1988 Jan; 34(1):201-4. PubMed ID: 3163875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and clinical evaluation of ofloxacin in urinary tract infection and enteric fever.
    Tanphaichitra D; Srimuang S
    Drugs Exp Clin Res; 1988; 14(8):529-31. PubMed ID: 3266853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of ofloxacin against complicated urinary tract infections].
    Nishio S; Yoshihara H
    Hinyokika Kiyo; 1987 Sep; 33(9):1503-7. PubMed ID: 3481217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
    Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
    Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ofloxacin: in vitro and in vivo activity.
    Guerra L; Caro B; Erani E; Xerri L
    Chemioterapia; 1987 Feb; 6(1):23-31. PubMed ID: 3470154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single dose of ofloxacin treatment in women with dysuria and frequency.
    Simşek F; Dillioğlugil O; Ilker Y; Akdaş A
    Int Urol Nephrol; 1993; 25(3):249-54. PubMed ID: 8225825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group.
    Mattina R; Cocuzza CE; Cesana M
    Infection; 1993; 21(2):106-11. PubMed ID: 8387963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open, non comparative study of ofloxacin i.v. on the treatment of acute symptomatic urinary tract infection.
    Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D
    J Med Assoc Thai; 2000 Jul; 83(7):771-5. PubMed ID: 10932512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral ofloxacin: a critical review of the new drug application.
    Sanders WE
    Clin Infect Dis; 1992 Feb; 14(2):539-54. PubMed ID: 1554843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral ofloxacin therapy of infections due to multiply-resistant bacteria.
    Scully BE; Clynes N; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(5):435-41. PubMed ID: 1797458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolones in urology.
    Nielsen KT; Madsen PO
    Urol Res; 1989; 17(2):117-24. PubMed ID: 2660393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of ofloxacin in infections which do not readily respond to treatment].
    Zalaudek G
    Antibiot Khimioter; 1996; 41(9):11-2. PubMed ID: 9005779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ofloxacin use in a geriatric population.
    Nicolle LE; Degelau J; Alessi P; Cullison J; Meyers B
    Chemotherapy; 1991; 37 Suppl 1():49-54. PubMed ID: 2049965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ofloxacin: a new ally in the treatment of urinary infections and bacterial prostatitis].
    Bravo JL
    Arch Esp Urol; 1992 Mar; 45(2):165-6. PubMed ID: 1567261
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ten-year experience with the use of ofloxacin (Tarivid*). New treatment regimens].
    Navashin SM; Navashin PS; Smirnova LB
    Antibiot Khimioter; 1996; 41(9):99-103. PubMed ID: 9005800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.